Atypical Antipsychotic Market Assessment by Indication Type
Atypical Antipsychotics Drugs
Some of the commonly used atypical antipsychotics drugs for the treatment of mental disorders are Ziprasidone, Paliperidone, Aripiprazole, Risperidone, Quetiapine, and others. A significant portion of the market has been covered by Quetiapine and Risperidone because they are inexpensive drugs used to treat schizophrenia and bipolar disorders. Moreover, the awareness towards mental disorders is primarily important, which leads to strong positioning of the drugs in the overall market.
Regional Market Outlook
Geographically, the global atypical antipsychotic market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa. North America will continue to dominate the global market due to large patient pool and high treatment rates. Europe is expected to hold second highest share in the global atypical antipsychotic market owing to increasing R&D efforts by the key players in the region. Asia Pacific is expected to have delayed growth in the atypical antipsychotics market. According to the Medical Council of India, many Indians are diagnosed with psychological disorders but due to lack of awareness, they are being untreated.
Competition Outlook
Examples of some of the key players identified in the global atypical antipsychotic market are GlaxoSmithKline Plc., Johnson and Johnson, Pfizer Inc., Eil Lilly and Company, Bristol-Myers Squibb Company, Allergan Plc., Cardinal Health Inc., Sanis Health Inc. , Ranbaxy Inc. (Sun Pharmaceutical Industries Ltd.), Novartis AG, etc.
Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6603
Small-Scale Manufacturers/Providers:
- Ranbaxy Inc. (Sun Pharmaceutical Industries Ltd.
Medium-Scale Manufacturers/Providers
- Cardinal Health Inc.
- Sanis Health Inc.
Large-Scale Manufacturers/Providers
- Bristol-Myers Squibb Company
- Novartis AG
- Allergan Plc.
- GlaxoSmithKline Plc.
- Johnson and Johnson
- Pfizer Inc.
- Eil Lilly and Company
Key data points covered in report
The report covers exhaustive analysis on:
- Atypical Antipsychotic Market by test type, end user and region
- Regional level market analysis of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, Middle East & Africa by test type, end user segments and country
- Atypical Antipsychotic Market Dynamics & Opportunity Assessment
- Historical Actual Market Size, 2013 – 2017
- Atypical Antipsychotic Market Size & Forecast 2018 – 2028
- Organ Function Assays Agents Current Trends/Issues/Challenges
- Competition & Companies involved
For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6603
By Drug Class
- Risperidone
- Olanzapine
- Quetiapine
- Ziprasidone
- Aripiprazole
- Paliperidone
- Lurasidone
By Indication
- Bipolar I Disorder
- Schizophrenia
- Schizoaffective Disorder
- Major Depressive Disorder (MDD)
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Drug Store
- E-commerce
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/